Taiwan Scientists Find Aspirin, Opioid Alternative In Sea Coral
This article was originally published in PharmAsia News
Taiwanese researchers are looking at locally grown soft coral as a treatment for pain treatment. Researchers at National Sun Yat-sen University report they have been able to isolate capnellene from Kenya Tree Coral, an element capable of reducing neuropathic pain significantly. The researchers say the treatment offers an alternative to aspirin or opioids, making it non-addictive and without side effects. The capnellene treatment is reported effective in reducing pain associated with inflamed nerve cells, and the researchers have applied for a patent for their compound. (Click here for more
You may also be interested in...
Purdue pleads guilty to three felony charges over marketing of OxyContin under settlement that requires Purdue to be dissolved and transformed into an entity that provides addiction and overdose medicines. Twenty-five state AGs oppose creation of a PBC, arguing Purdue should be sold to another company.
Abbott reported strong sales for diagnostics and devices in the third quarter and raised its full-year EPS guidance to $3.55 per share.
Vifor CEO Stefan Schulze tells Scrip that an expanded deal with Korsuva developer Cara Therapeutics means the US biotech will not have to invest in a commercial organization as the Swiss firm will mobilize its well-established sales force to launch the treatment for dialysis patients with CKD-associated pruritus.